Literature DB >> 16606836

Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism.

Nelly Pitteloud1, James S Acierno, Astrid Meysing, Anna V Eliseenkova, Jinghong Ma, Omar A Ibrahimi, Daniel L Metzger, Frances J Hayes, Andrew A Dwyer, Virginia A Hughes, Maria Yialamas, Janet E Hall, Ellen Grant, Moosa Mohammadi, William F Crowley.   

Abstract

Mutations in KAL1 and FGFR1 cause Kallmann syndrome (KS), whereas mutations in the GNRHR and GPR54 genes cause idiopathic hypogonadotropic hypogonadism with normal olfaction (nIHH). Mixed pedigrees containing both KS and nIHH have also been described; however, the genetic cause of these rare cases is unknown. We examined the FGFR1 gene in seven nIHH subjects who either belonged to a mixed pedigree (n = 5) or who had associated midline defects (n = 2). Heterozygous FGFR1 mutations were found in three of seven unrelated nIHH probands with normal MRI of the olfactory system: (i) G237S in an nIHH female and a KS brother; (ii) (P722H and N724K) in an nIHH male missing two teeth and his mother with isolated hyposmia; and (iii) Q680X in a nIHH male with cleft lip/palate and missing teeth, his brother with nIHH, and his father with delayed puberty. We show that these mutations lead to receptor loss-of-function. The Q680X leads to an inactive FGFR1, which lacks a major portion of the tyrosine kinase domain (TKD). The G237S mutation inhibits proper folding of D2 of the FGFR1 and likely leads to the loss of cell-surface expression of FGFR1. In contrast, the (P722H and N724K) double mutation causes structural perturbations in TKD, reducing the catalytic activity of TKD. We conclude that loss-of-function mutations in FGFR1 cause nIHH with normal MRI of the olfactory system. These mutations also account for some of the mixed pedigrees, thus challenging the current idea that KS and nIHH are distinct entities.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16606836      PMCID: PMC1458869          DOI: 10.1073/pnas.0600962103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules.

Authors:  B Franco; S Guioli; A Pragliola; B Incerti; B Bardoni; R Tonlorenzi; R Carrozzo; E Maestrini; M Pieretti; P Taillon-Miller; C J Brown; H F Willard; C Lawrence; M Graziella Persico; G Camerino; A Ballabio
Journal:  Nature       Date:  1991-10-10       Impact factor: 49.962

2.  Prenatal diagnosis and investigation of a fetus with chondrodysplasia punctata, ichthyosis, and Kallmann syndrome due to an Xp deletion.

Authors:  D P Bick; D F Schorderet; P A Price; L Campbell; R W Huff; L J Shapiro; C M Moore
Journal:  Prenat Diagn       Date:  1992-01       Impact factor: 3.050

3.  Sex differences in odor identification ability: a cross-cultural analysis.

Authors:  R L Doty; S Applebaum; H Zusho; R G Settle
Journal:  Neuropsychologia       Date:  1985       Impact factor: 3.139

4.  Idiopathic hypothalamic hypogonadotropic hypogonadism with polyostotic fibrous dysplasia.

Authors:  R Shires; M P Whyte; L V Avioli
Journal:  Arch Intern Med       Date:  1979-10

5.  Clinical and laboratory heterogeneity in idiopathic hypogonadotropic hypogonadism.

Authors:  R M Boyar; R H Wu; S Kapen; L Hellman; E D Weitzman; J W Finkelstein
Journal:  J Clin Endocrinol Metab       Date:  1976-12       Impact factor: 5.958

6.  Episodic luteinizing hormone secretion in man. Pulse analysis, clinical interpretation, physiologic mechanisms.

Authors:  R J Santen; C W Bardin
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

7.  Methodology employed for the structure determination of tumour necrosis factor, a case of high non-crystallographic symmetry.

Authors:  E Y Jones; N P Walker; D I Stuart
Journal:  Acta Crystallogr A       Date:  1991-11-01       Impact factor: 2.290

8.  The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules.

Authors:  R Legouis; J P Hardelin; J Levilliers; J M Claverie; S Compain; V Wunderle; P Millasseau; D Le Paslier; D Cohen; D Caterina
Journal:  Cell       Date:  1991-10-18       Impact factor: 41.582

9.  X chromosome-linked Kallmann syndrome: stop mutations validate the candidate gene.

Authors:  J P Hardelin; J Levilliers; I del Castillo; M Cohen-Salmon; R Legouis; S Blanchard; S Compain; P Bouloux; J Kirk; C Moraine
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

10.  Heterogeneity in the mutations responsible for X chromosome-linked Kallmann syndrome.

Authors:  J P Hardelin; J Levilliers; S Blanchard; J C Carel; M Leutenegger; J P Pinard-Bertelletto; P Bouloux; C Petit
Journal:  Hum Mol Genet       Date:  1993-04       Impact factor: 6.150

View more
  86 in total

1.  Olfactory phenotypic spectrum in idiopathic hypogonadotropic hypogonadism: pathophysiological and genetic implications.

Authors:  Hilana M Lewkowitz-Shpuntoff; Virginia A Hughes; Lacey Plummer; Margaret G Au; Richard L Doty; Stephanie B Seminara; Yee-Ming Chan; Nelly Pitteloud; William F Crowley; Ravikumar Balasubramanian
Journal:  J Clin Endocrinol Metab       Date:  2011-11-09       Impact factor: 5.958

2.  Commentary: the year in endocrine genetics for basic scientists.

Authors:  William F Crowley
Journal:  Mol Endocrinol       Date:  2011-11-22

Review 3.  Deciphering genetic disease in the genomic era: the model of GnRH deficiency.

Authors:  Gerasimos P Sykiotis; Nelly Pitteloud; Stephanie B Seminara; Ursula B Kaiser; William F Crowley
Journal:  Sci Transl Med       Date:  2010-05-19       Impact factor: 17.956

Review 4.  Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism.

Authors:  Claire Bouvattier; Luigi Maione; Jérôme Bouligand; Catherine Dodé; Anne Guiochon-Mantel; Jacques Young
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

5.  Fibroblast growth factor signaling deficiencies impact female reproduction and kisspeptin neurons in mice.

Authors:  Brooke K Tata; Wilson C J Chung; Leah R Brooks; Scott I Kavanaugh; Pei-San Tsai
Journal:  Biol Reprod       Date:  2012-04-19       Impact factor: 4.285

6.  Impaired FGF signaling contributes to cleft lip and palate.

Authors:  Bridget M Riley; M Adela Mansilla; Jinghong Ma; Sandra Daack-Hirsch; Brion S Maher; Lisa M Raffensperger; Erilynn T Russo; Alexandre R Vieira; Catherine Dodé; Moosa Mohammadi; Mary L Marazita; Jeffrey C Murray
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-06       Impact factor: 11.205

7.  The neurokinin B pathway in human reproduction.

Authors:  Ana Claudia Latronico
Journal:  Nat Genet       Date:  2009-03       Impact factor: 38.330

8.  Clinical assessment and genomic landscape of a consanguineous family with three Kallmann syndrome descendants.

Authors:  Shi-Lin Zhang; Yan-Ping Tang; Tao Wang; Jun Yang; Ke Rao; Ling-Yun Zhao; Wen-Zhen Zhu; Xiang-Hu Meng; Shao-Gang Wang; Ji-Hong Liu; Wei-Min Yang; Zhang-Qun Ye
Journal:  Asian J Androl       Date:  2010-11-01       Impact factor: 3.285

Review 9.  Kinase mutations in human disease: interpreting genotype-phenotype relationships.

Authors:  Piya Lahiry; Ali Torkamani; Nicholas J Schork; Robert A Hegele
Journal:  Nat Rev Genet       Date:  2010-01       Impact factor: 53.242

10.  Kallmann syndrome.

Authors:  Catherine Dodé; Jean-Pierre Hardelin
Journal:  Eur J Hum Genet       Date:  2008-11-05       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.